Imagine dedicating years of your life to a sport, only to have it all jeopardized by a single decision. That’s the harsh reality for two young pitchers, Luis Custodio and Luis Sierra, who have been suspended for 56 games each after testing positive for banned substances. But here’s where it gets controversial: while their actions are undeniably against the rules, does the severity of the punishment fit the crime, especially for athletes so early in their careers? Let’s dive into the details.
In a move that sent shockwaves through the minor league baseball community, the commissioner’s office announced on Monday that San Francisco Giants prospect Luis Custodio and free agent Luis Sierra had been suspended under the minor league drug program for players outside the U.S. and Canada. Both tested positive for Stanozolol, a performance-enhancing substance notorious in sports scandals. And this is the part most people miss: these suspensions aren’t just about breaking rules—they’re about the broader implications for young athletes’ futures and the integrity of the game.
Custodio, a 21-year-old left-handed pitcher, had been working his way back from Tommy John surgery, posting a 2-1 record with a 7.94 ERA in 12 relief appearances for the Giants Black in the Dominican Summer League last year. Signed by the Giants in 2023, he was seen as a promising talent with potential to grow. Sierra, a 20-year-old right-hander, had a brief stint with the Baltimore Orioles after signing for a $10,000 bonus last June. He struggled with a 0-2 record and a 9.95 ERA in 11 relief appearances for the DSL Orioles before being released on January 5. His suspension will take effect only if he signs with another major league organization—a significant hurdle for a player already facing an uphill battle.
Here’s a thought-provoking question: Are these suspensions a fair deterrent, or do they disproportionately punish young athletes who may lack proper education about banned substances? It’s a debate worth having, especially as Sierra’s career now hangs in the balance.
This isn’t an isolated incident. Earlier this year, free agent outfielder Max Kepler was suspended for 80 games under the major league program after testing positive for Epitrenbolone. With three suspensions already in 2023, it’s clear that the issue of performance-enhancing drugs remains a persistent challenge in baseball. But here’s the kicker: while the rules are clear, the human stories behind these suspensions are complex. Custodio and Sierra are just two of many young athletes navigating the pressures of professional sports, where the line between ambition and misconduct can blur.
As we reflect on these cases, it’s worth asking: What more can organizations do to educate players about the risks of banned substances? And should the punishment for first-time offenders be more rehabilitative than punitive? Let us know your thoughts in the comments—this is a conversation that needs to happen.
